Lipid Lowering Effect of Plant Stanol Ester in a Drinkable Non-dairy Product

Inclusion Criteria: * Signed written informed consent * Mildly or moderately elevated plasma cholesterol levels (plasma total cholesterol 5.5-8.0 mmol/l) * Plasma triglyceride levels ≤ 4.0 mmol/l * Age 18-65 years Exclusion Criteria: * Intolerance to oats or other ingredients of the test products * Severe obesity (BMI ≥ 32 kg/m2) * Consumption of lipid/cholesterol lowering medication (e.g. ezetimibe, PCSK9 inhibitors, resins, fibrates) 1 month prior to the screening visit and throughout the study. Statin treatment is allowed at stable dose. * Consumption of plant stanol or plant sterol containing food products or supplements or other foods or supplements such as beta-glucan enriched foods, red rice, berberine or any combination of these used for cholesterol lowering purpose 1 month prior the study entry (baseline blood sample) * History of malignant diseases like cancer within five years prior to recruitment * History of unstable coronary artery disease (myocardial infarction, coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA) within the previous 6 months * Diagnosed type 1 or type 2 diabetes requiring medical treatment * Celiac disease * Medically prescribed diet/treatment for slimming or a special diet like very low calorie diet or use of prescribed an obesity drug (e.g. Orlistat, Victoza) * Alcohol abuse (\> 4 portion/per day) or recreational drug abuse * Pregnancy or planned pregnancy or lactating * Clinically significant abnormalities in screening labs * Participation in another clinical trial in the preceding 3 months